For women with hormone-receptor positive (HR+) invasive breast cancer, treatment with endocrine therapy and radiation therapy as part of breast conservation is the current standard of care. A new study by researchers at Fox Chase Cancer Center, however, shows that combination may not be necessary for all patient populations with the disease. The results, which Fox Chase researchers presented at the American Society for Radiation Oncology's 56th Annual ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment